Prednisone-free maintenance immunosuppression-a 5-year experience. - Wikidata - wikimedia - TriplyDB

Prednisone-free maintenance immunosuppression-a 5-year experience.

Prednisone-free maintenance immunosuppression-a 5-year experience.

http://www.wikidata.org/entity/Q46702753

about

Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients Steroid avoidance or withdrawal for pancreas and kidney transplant recipients Steroid avoidance or withdrawal for kidney transplant recipients New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity Steroid avoidance or withdrawal for kidney transplant recipients.Thymoglobulin--new approaches to optimal outcomes.Impact of steroid maintenance on the outcomes in first-time deceased donor kidney transplant recipients: Analysis by induction type Early steroid withdrawal in repeat kidney transplantation.Role of steroid maintenance in sensitized kidney transplant recipients.Steroid withdrawal after renal transplantation: a retrospective cohort study.Developments in clinical islet, liver thoracic, kidney and pancreas transplantation in the last 5 years.Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation.Recurrent glomerulonephritis under rapid discontinuation of steroids.Impact of Maintenance Steroids versus Rapid Steroid Withdrawal in African-American Kidney Transplant Recipients: Comparison of Two Urban Centers.Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression Minimizing immunosuppression, an alternative approach to reducing side effects: objectives and interim result.Cardiovascular disease in transplant recipients: current and future treatment strategies.Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits.Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?Steroid-free immunosuppression in pediatric renal transplantation: rationale for and [corrected] outcomes following conversion to steroid based therapy.2202 kidney transplant recipients with 10 years of graft function: what happens next?Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti-IL2 Receptor Monoclonal Antibodies?Steroid minimization for sirolimus-treated renal transplant recipients.Current landscape for T-cell targeting in autoimmunity and transplantation.Very early steroid withdrawal or complete avoidance for kidney transplant recipients: a systematic review.Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.Steroid withdrawal in kidney allograft recipients.An in-progress, open-label, multi-centre study (SAILOR) evaluating whether a steroid-free immunosuppressive protocol, based on ATG induction and a low tacrolimus dose, reduces the incidence of new onset diabetes after transplantation Renal association clinical practice guideline in post-operative care in the kidney transplant recipient Impact of acute rejection on kidney allograft outcomes in recipients on rapid steroid withdrawal.Steroid minimization in liver transplant recipients: impact on hepatitis C recurrence and post-transplant diabetes.Late conversion of tacrolimus to sirolimus in a prednisone-free immunosuppression regimen in renal transplant patients.Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.Kidney allograft survival after acute rejection, the value of follow-up biopsies.Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient.Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6-Month Course of Steroids

P2860

Q24193602-FE0BB847-61EA-406A-B9A5-21079BC4627F Q24240624-8735D684-0887-4FB1-88B1-E6068D4A1EC8 Q24240985-BEB86BCF-BD8C-415B-9E9D-41D2153825B3 Q26823090-4562863C-25B3-406D-AF1D-0941C62A1A03 Q30248364-D445A72A-99C7-4865-90B2-F2DFBA412D94 Q33388015-202D51D9-83F8-4B95-817D-B00BF57CB10E Q34397386-65FC1021-E6F9-4757-9E5E-7956159FB403 Q34639731-0A61B6BC-5558-4EAE-AD32-FCB606569061 Q36087762-DB8AA794-D5BB-4700-80F8-58095B73C84E Q36246782-24C1E8F0-E1A3-474A-80B2-7224AA015D83 Q36505718-7D72C6B5-C01B-4CCC-BE6E-A427F1BC3683 Q36752004-C659108F-4E36-49F0-B638-7DD87DCA01A2 Q36790053-FDE6047C-D82F-443C-BCD6-4C3483E3B303 Q36793414-38290E0C-859C-47DC-B302-B2BD1D664D4D Q37060473-1FAF7EB9-B0CC-4421-8973-75A5BCECB2E6 Q37097694-AF1CF6A9-ED4D-4B34-8D91-F1B4D423AA42 Q37097700-5683E9CD-B129-47A7-B87F-89C5E411D5A2 Q37300420-1D296065-F2D0-41C3-A97A-85987197CC51 Q37318299-537BD738-1007-4D1B-81B3-2D85CDB3529E Q37377947-6D22CE63-9D47-4FAF-93E6-67331EE563EB Q37397106-6AE4F537-A62F-4BE8-8DE2-1A640AF56C5E Q37561282-DBEB7D90-517C-42FA-8B7C-7CAF4C9F52B0 Q37760246-78B52BC3-E656-4E94-8927-3D071D1481B2 Q37900647-FE58BC63-1E89-4707-AF26-44D483BA736D Q37904538-2A849617-4C02-484D-BBF3-91463D3C22E7 Q38047203-309261A4-1FF2-44AF-B7F4-5F3B158BF8F2 Q38239572-E564B4BB-A741-4D8E-9E84-E34635C8ADC8 Q41015774-B9803012-BC9D-48A6-AFE9-DC3FACB7413B Q42343473-6EDA6050-0A89-4511-85C8-5FA648519607 Q42740954-74A46739-4C67-45B0-A377-E078268471EE Q43039439-482F5F23-4FCE-44E5-BCB4-61AB2DB769F4 Q43297747-34D7B1C8-07F3-4EEF-B675-E11D588E8CB0 Q44376334-F9D2259B-C4FB-4E34-BE7E-B85DF29533D4 Q46211382-3DC6D94C-0A25-48EA-AE11-52263123F5FF Q52845695-E96208B7-FAF1-478C-A1AE-D6867A64970E Q56908156-6317B7E7-06D8-44E3-950F-15B1ECF4C6E0

P2860

Prednisone-free maintenance immunosuppression-a 5-year experience.

http://www.wikidata.org/entity/Q46702753

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Prednisone-free maintenance immunosuppression-a 5-year experience.

@en

Prednisone-free maintenance immunosuppression-a 5-year experience.

@nl

type

label

Prednisone-free maintenance immunosuppression-a 5-year experience.

@en

Prednisone-free maintenance immunosuppression-a 5-year experience.

@nl

prefLabel

Prednisone-free maintenance immunosuppression-a 5-year experience.

@en

Prednisone-free maintenance immunosuppression-a 5-year experience.

@nl

P1433

Q46702753-B621A683-02E1-402C-A2D7-D6B05E96614D

P1476

Q46702753-25C2D2A5-949D-4A2A-A062-F43A4AC35927

P2093

Q46702753-10D8CDBF-EE7E-4364-9E50-35D8B35DEECC

Q46702753-24DF289B-ECA9-4954-9B67-2206E290BB6B

Q46702753-29C5056B-9EA5-4EBC-9E70-015FC2F4DADA

Q46702753-54B7A6C1-463A-4930-8B30-75A14D1DE6A5

Q46702753-7AF4F18D-1662-4385-8C6A-6A2BAD0CA496

Q46702753-BF4CCC25-2076-46EC-BBBE-68F4E967781A

Q46702753-F571B06D-9BAB-42EA-93B9-CF457DC0B7FA

P2860

Q46702753-09D62637-7B1D-4B2C-8095-06711BCF5D1D

Q46702753-15DCCA4A-A2F3-4B66-BD5A-27C2ABC9ABC1

Q46702753-1A9C5660-96EF-4968-A01F-07CD967A7DCF

Q46702753-20077D4F-56D3-4D8E-A102-A2B9CC991DB6

Q46702753-2238F6F1-0EBF-482E-B5AF-0952F372CE13

Q46702753-24325324-B7EB-44A9-A3A2-93D86469BB8E

Q46702753-3224B21A-5DBA-4F95-BE4A-A7AE5AAD35E4

Q46702753-480A8272-469F-4206-988E-CAE33C166470

Q46702753-582704FF-9810-4EBD-B875-57D65219AA90

Q46702753-5A9D3010-E203-476C-BD88-D02B41A8CAA8

P304

Q46702753-67136209-CF6F-4A4C-92C2-F8790B49B2C2

P31

Q46702753-D339C70A-89D2-4456-87DE-1C6B3D4228AF

P356

Q46702753-B8AB5713-BF09-4702-ABD2-A914EFDD7CA5

P407

Q46702753-1CD428EF-248D-4151-B685-91F8E4699B86

P433

Q46702753-BF514DFF-2C62-4523-8371-B855F10825AA

P478

Q46702753-35CBA659-B7BA-404A-8340-604870BE9D33

P577

Q46702753-5B5B0596-EC2B-40AA-816C-FB3CA52BBF62

P5875

Q46702753-C71DF892-ED5C-48C3-81E9-35B496C88778

P698

Q46702753-9D92886A-6714-4728-8E51-E41A75088E81

P921

Q46702753-75930B7F-4A7E-464B-A7EA-B79892868DF8

P356

J.1600-6143.2005.01051.X

P1433

American Journal of Transplantation

P1476

Prednisone-free maintenance immunosuppression-a 5-year experience.

@en

P2093

Abhinav Humar

http://www.w3.org/2001/XMLSchema#string

Arthur J Matas

http://www.w3.org/2001/XMLSchema#string

Bertram Kasiske

http://www.w3.org/2001/XMLSchema#string

Hassan Ibrahim

http://www.w3.org/2001/XMLSchema#string

Kristen J Gillingham

http://www.w3.org/2001/XMLSchema#string

Lois McHugh

http://www.w3.org/2001/XMLSchema#string

Raja Kandaswamy

http://www.w3.org/2001/XMLSchema#string

P2860

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients.

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal.

An alternate mechanism of glucocorticoid anti-proliferative effect: promotion of a Th2 cytokine-secreting profile.

Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation.

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

Rapid steroid withdrawal versus standard steroid therapy in patients treated with basiliximab, cyclosporine, and mycophenolate mofetil for the prevention of acute rejection in renal transplantation.

Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients.

A pilot study of steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients.

P304

2473-2478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-6143.2005.01051.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2005-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7601132

http://www.w3.org/2001/XMLSchema#string

P698

16162197

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression